Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

• Autors principals: Jose Navarro-Partida (Autor), Juan Carlos Altamirano-Vallejo (Autor), Luis Abraham Aceves Franco (Autor), Jesús Gonzalez-Cortes (Autor), Sergio Hernandez-Da Mota (Autor), Jose Gerardo García-Aguirre (Autor), Carlos David Azuara-Galindo (Autor), Carlos Rodrigo Castro-Castaneda (Autor), Juan Armendariz-Borunda (Autor), Arturo Santos (Autor)
• Format: Llibre
• Publicat: MDPI AG, 2021-09-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Novel strategies have been developed to reduce or avoid intravitreal injections (IVTs) of the antiangiogenic (ranibizumab (RBZ)) and anti-inflammatory (triamcinolone acetonide (TA)) agents used to treat vitreoretinal diseases. One of the strategies includes liposomes. This study evaluated the safety...